Ann Yung
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ann Yung has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Reza Dana
Laboratory of Ocular Immunology, Transplantation and Regeneration, Schepens Eye Research Institute of Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA
5 shared publications - Nasim Annabi
Department of Chemical Engineering, Northeastern University, Boston, MA, 02115, USA; Biomaterials Innovation Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA; Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA
4 shared publications - Rohan Bir Singh
Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA
4 shared publications - Thomas H. Dohlman
Harvard Medical School
4 shared publications Reza Dana
Schepens Eye Research Institute of Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, USA
3 shared publicationsClotilde Jumelle
Schepens Eye Research Institute, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts 02114, United States
2 shared publications
Latest Publications
- Open Access
- 28 May 2025
- Published by Elsevier in Acta Biomaterialia
- Vol. 201, 517-533
Mucoadhesive micellar eyedrops for the treatment of ocular inflammation
- 28 May 2025
- Published by Elsevier in Acta Biomaterialia
- Vol. 201, 517-533
Open AccessMucoadhesive micellar eyedrops for the treatment of ocular inflammation
- 20 October 2022
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 11 (4) , 1318-1334
Development and optimization of an ocular hydrogel adhesive patch using definitive screening design (DSD)
Adhesive hydrogels based on chemically modified photocrosslinkable polymers with specific physicochemical properties are frequently utilized for sealing wounds or incisions. These adhesive hydrogels offer tunable characteristics such as tailorable tissue adhesion, mechanical properties, swelling ratios, and enzymatic degradability. In this study, we developed and optimized a photocrosslinkable adhesive patch, GelPatch, with high burst pressure, minimal swelling, and specific mechanical properties for application as an ocular (sclera and subconjunctival) tissue adhesive. To achieve this, we formulated a series of hydrogel patches composed of different polymers with various levels of methacrylation, molecular weights, and hydrophobic/hydrophilic properties. A computerized multifactorial definitive screening design (DSD) analysis was performed to identify the most prominent components impacting critical response parameters such as adhesion, swelling ratio, elastic modulus, and second order interactions between applied components. These parameters were mathematically processed to generate a predictive model that identifies the linear and non-linear correlations between these factors. In conclusion, an optimized formulation of GelPatch was selected based on two modified polymers: gelatin methacryloyl (GelMA) and glycidyl methacrylated hyaluronic acid (HAGM). The ex vivo results confirmed adhesion and retention of the optimized hydrogel subconjunctivally and on the sclera for up to 4 days. The developed formulation has potential to be used as an ocular sealant for quick repair of laceration type ocular injuries.
- 20 October 2022
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 11 (4) , 1318-1334
Development and optimization of an ocular hydrogel adhesive patch using definitive screening design (DSD)
Adhesive hydrogels based on chemically modified photocrosslinkable polymers with specific physicochemical properties are frequently utilized for sealing wounds or incisions. These adhesive hydrogels offer tunable characteristics such as tailorable tissue adhesion, mechanical properties, swelling ratios, and enzymatic degradability. In this study, we developed and optimized a photocrosslinkable adhesive patch, GelPatch, with high burst pressure, minimal swelling, and specific mechanical properties for application as an ocular (sclera and subconjunctival) tissue adhesive. To achieve this, we formulated a series of hydrogel patches composed of different polymers with various levels of methacrylation, molecular weights, and hydrophobic/hydrophilic properties. A computerized multifactorial definitive screening design (DSD) analysis was performed to identify the most prominent components impacting critical response parameters such as adhesion, swelling ratio, elastic modulus, and second order interactions between applied components. These parameters were mathematically processed to generate a predictive model that identifies the linear and non-linear correlations between these factors. In conclusion, an optimized formulation of GelPatch was selected based on two modified polymers: gelatin methacryloyl (GelMA) and glycidyl methacrylated hyaluronic acid (HAGM). The ex vivo results confirmed adhesion and retention of the optimized hydrogel subconjunctivally and on the sclera for up to 4 days. The developed formulation has potential to be used as an ocular sealant for quick repair of laceration type ocular injuries.
- 19 October 2021
- Published by Elsevier in Acta Biomaterialia
- Vol. 137, 53-63
Development and characterization of a hydrogel-based adhesive patch for sealing open-globe injuries
- 19 October 2021
- Published by Elsevier in Acta Biomaterialia
- Vol. 137, 53-63
Development and characterization of a hydrogel-based adhesive patch for sealing open-globe injuries
- 16 May 2021
- Published by Elsevier in The Ocular Surface
- Vol. 21, 134-144
Ocular redness – I: Etiology, pathogenesis, and assessment of conjunctival hyperemia
- 16 May 2021
- Published by Elsevier in The Ocular Surface
- Vol. 21, 134-144
Ocular redness – I: Etiology, pathogenesis, and assessment of conjunctival hyperemia
- 15 May 2021
- Published by Elsevier in The Ocular Surface
- Vol. 21, 66-77
Ocular redness – II: Progress in development of therapeutics for the management of conjunctival hyperemia
- 15 May 2021
- Published by Elsevier in The Ocular Surface
- Vol. 21, 66-77
Ocular redness – II: Progress in development of therapeutics for the management of conjunctival hyperemia
- 15 September 2020
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 8 (18) , 5196-5209
Ciprofloxacin-loaded bioadhesive hydrogels for ocular applications
The management of corneal infections often requires complex therapeutic regimens involving the prolonged and high-frequency application of antibiotics that provide many challenges to patients and impact compliance with the therapeutic regimens. In the context of severe injuries that lead to tissue defects (e.g. corneal lacerations) topical drug regimens are inadequate and suturing is often indicated. There is thus an unmet need for interventions that can provide tissue closure while concurrently preventing or treating infection. In this study, we describe the development of an antibacterial bioadhesive hydrogel loaded with micelles containing ciprofloxacin (CPX) for the management of corneal injuries at risk of infection. The in vitro release profile showed that the hydrogel system can release CPX, a broad-spectrum antibacterial drug, for up to 24 h. Moreover, the developed CPX-loaded hydrogels exhibited excellent antibacterial properties against Staphylococcus aureus and Pseudomonas aeruginosa, two bacterial strains responsible for the most ocular infections. Physical characterization, as well as adhesion and cytocompatibility tests, were performed to assess the effect of CPX loading in the developed hydrogel. Results showed that CPX loading did not affect stiffness, adhesive properties, or cytocompatibility of hydrogels. The efficiency of the antibacterial hydrogel was assessed using an ex vivo model of infectious pig corneal injury. Corneal tissues treated with the antibacterial hydrogel showed a significant decrease in bacterial colony-forming units (CFU) and a higher corneal epithelial viability after 24 h as compared to non-treated corneas and corneas treated with hydrogel without CPX. These results suggest that the developed adhesive hydrogel system presents a promising suture-free solution to seal corneal wounds while preventing infection.
- 15 September 2020
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 8 (18) , 5196-5209
Ciprofloxacin-loaded bioadhesive hydrogels for ocular applications
The management of corneal infections often requires complex therapeutic regimens involving the prolonged and high-frequency application of antibiotics that provide many challenges to patients and impact compliance with the therapeutic regimens. In the context of severe injuries that lead to tissue defects (e.g. corneal lacerations) topical drug regimens are inadequate and suturing is often indicated. There is thus an unmet need for interventions that can provide tissue closure while concurrently preventing or treating infection. In this study, we describe the development of an antibacterial bioadhesive hydrogel loaded with micelles containing ciprofloxacin (CPX) for the management of corneal injuries at risk of infection. The in vitro release profile showed that the hydrogel system can release CPX, a broad-spectrum antibacterial drug, for up to 24 h. Moreover, the developed CPX-loaded hydrogels exhibited excellent antibacterial properties against Staphylococcus aureus and Pseudomonas aeruginosa, two bacterial strains responsible for the most ocular infections. Physical characterization, as well as adhesion and cytocompatibility tests, were performed to assess the effect of CPX loading in the developed hydrogel. Results showed that CPX loading did not affect stiffness, adhesive properties, or cytocompatibility of hydrogels. The efficiency of the antibacterial hydrogel was assessed using an ex vivo model of infectious pig corneal injury. Corneal tissues treated with the antibacterial hydrogel showed a significant decrease in bacterial colony-forming units (CFU) and a higher corneal epithelial viability after 24 h as compared to non-treated corneas and corneas treated with hydrogel without CPX. These results suggest that the developed adhesive hydrogel system presents a promising suture-free solution to seal corneal wounds while preventing infection.
- 19 August 2020
- Published by Elsevier in The Ocular Surface
- Vol. 18 (4) , 795-800
Efficacy of cyanoacrylate tissue adhesive in the management of corneal thinning and perforation due to microbial keratitis
- 19 August 2020
- Published by Elsevier in The Ocular Surface
- Vol. 18 (4) , 795-800
Efficacy of cyanoacrylate tissue adhesive in the management of corneal thinning and perforation due to microbial keratitis
- 30 July 2020
- Published by Elsevier in The Ocular Surface
- Vol. 18 (4) , 731-735
Efficacy and retention of silicone punctal plugs for treatment of dry eye in patients with and without ocular graft-versus-host-disease
- 30 July 2020
- Published by Elsevier in The Ocular Surface
- Vol. 18 (4) , 731-735
Efficacy and retention of silicone punctal plugs for treatment of dry eye in patients with and without ocular graft-versus-host-disease